Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer.

CONCLUSION: In conclusion, ERCC1 was identified as a potential biomarker of platinum response overall survival in HGSOC undergoing neoadjuvant HGSOC treatment.
PMID: 30194007 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - September 4, 2018 Category: Cancer & Oncology Authors: Scurry J, van Zyl B, Gulliver D, Otton G, Jaaback K, Lombard J, Vilain RE, Bowden NA Tags: Gynecol Oncol Source Type: research